Romano Brothers & Co’s Bio-Techne TECH Stock Holding History

Romano Brothers & Co’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-72	Closed	-$5.97K	–	906
2022 Q4	$5.97K	Buy	+72	New	+$5.72K	﹤0.01%	809

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Romano Brothers & Co's TECH Position: Q1 2023 in Review

Romano Brothers & Co sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 72 shares — an estimated $5.97K sold.

Romano Brothers & Co first reported a position in TECH in Q4 2022 and held it in 1 quarter. The position peaked at $5.97K in Q4 2022. 549 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Romano Brothers & Co reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 72 Bio-Techne shares in Q1 2023, an estimated $5.97K.
Romano Brothers & Co first reported a position in Bio-Techne in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Bio-Techne position peaked at $5.97K in Q4 2022.
549 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.